UK government, pharma industry still far away from life sciences plan agreement
LONDON (Reuters) -The British government and the pharmaceutical industry remain far apart in a dispute over drug pricing that has delayed publication of a long-pending plan for the UK life sciences sector. WHY IT’S IMPORTANT The review is intended to outline how the UK can cut red tape and boost a sector the government identifies …
UK government, pharma industry still far away from life sciences plan agreement Read More »









